Thursday, July 3rd, 2025

Thai Beverage’s stock is currently trading with a bullish chart outlook

Thai Beverage (THBEV SP)

Technical Overview and Stock Performance:

  • Current Price: S$0.525
  • Target Price: S$0.585
  • Protective Stop: S$0.505

Thai Beverage’s stock is currently trading with a bullish chart outlook, as its price remains above the cloud, which signals the continuation of an upward trend. Additionally, the conversion and base lines are in a bullish crossover, further affirming the positive trajectory. The MACD (Moving Average Convergence Divergence) also shows bullish signals, with the likelihood of a bullish crossover in the near future. These indicators suggest the possibility of the stock price increasing in the coming days.

  • Investment Recommendation: The analysis recommends a Trading Buy with a price target of S$0.585, reflecting potential upside for investors. The stop-loss level is set at S$0.505 to mitigate downside risks.
  • Approximate Timeframe: The expected timeframe for this trade idea is 1-2 weeks, with the caveat that the trade should be initiated if the stock hits the entry price range within three trading days.

ThaiBev remains a strong contender due to its stable fundamentals and potential price appreciation in the short term.  Thank you

💰 Fed’s Game-Changing Rule Shift May Unlock US$6 Trillion for Wall Street Giants. The Week’s Hottest Market Plays – Boustead’s Breakout,Co-Living Booms, and Raffles Medical’s Rise.

Wall Street banks may be on the cusp of a massive windfall as the U.S. Federal Reserve proposes a major revision to capital rules. Analysts estimate the change could unlock as much as US$6...

Sunway Poised for Breakout as Bulls Retain Control in Sideways Consolidation

Sunway Poised for Breakout as Bulls Retain Control in Sideways Consolidation

BeiGene Ltd (6160) Surges Amid Bullish Technicals: A Promising Investment Opportunity

Company HighlightsBeiGene Ltd (HKG: 6160) has recently emerged as a strong contender for investors looking for growth in the biopharmaceutical sector. As a commercial-stage company specializing in the discovery and commercialization of molecularly targeted...